Detection of Hepatic Metastases in Breast Cancer
- 1 May 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 14 (3), 366-374
- https://doi.org/10.1097/00004728-199005000-00008
Abstract
Nonenhanced and enhanced CT was compared in 88 patients with breast cancer and hepatic metastasis. Twenty-five patients had bolus, sequential dynamic CT, and 63 patients were scanned more slowly after a bolus or during drip infusion. Metastatic lesions were more conspicuous on nonenhanced CT and became isodense or nearly isodense after contrast medium administration in 28% of the patients scanned dynamically and in 29% of those scanned more slowly. Although breast cancer has not generally been considered a common origin of hypervascular metastases, we recommended that it be treated as such and that both enhanced and nonenhanced CT of the liver be obtained when patients are screened for metastasis.This publication has 8 references indexed in Scilit:
- CT of the liver: a survey of prevailing methods for administration of contrast materialAmerican Journal of Roentgenology, 1988
- Hypervascular hepatic metastases: CT evaluation.Radiology, 1987
- Patterns of contrast enhancement of benign and malignant hepatic neoplasms during bolus dynamic and delayed CT.Radiology, 1986
- Focal hepatic masses and fatty infiltration detected by enhanced dynamic CT.Radiology, 1986
- Contrast enhancement technique for dynamic hepatic computed tomographic scanning.Radiology, 1983
- Contrast enhancement of focal hepatic lesions in CT: effect of size and histologyAmerican Journal of Roentgenology, 1983
- Contrast enhancement of hepatic tumors in CT: comparison between bolus and infusion techniquesAmerican Journal of Roentgenology, 1983
- A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics.Radiology, 1980